Zimmer Biomet Holdings (ZBH) Asset Writedowns and Impairment (2009 - 2022)

Zimmer Biomet Holdings' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $289.8 million for Q4 2022.

• In Q4 2022, Asset Writedowns and Impairment changed N/A year-over-year to $289.8 million; the TTM figure through Dec 2022 stood at $292.8 million (up 332.94% YoY), while the FY2022 annual figure was $292.8 million, up 1696.32% from the prior year.
• Asset Writedowns and Impairment for Q4 2022 stood at $289.8 million, up from $3.0 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $975.9 million in Q4 2018, with the low at -$142.0 million in Q4 2020.
• The 5-year median for Asset Writedowns and Impairment is $33.0 million (2020), against an average of $206.9 million.
• Peak annual rise in Asset Writedowns and Impairment reached 258.79% in 2018, while the deepest fall reached 88.38% in 2018.
• Zimmer Biomet Holdings' Asset Writedowns and Impairment stood at $975.9 million in 2018, then sank by 92.82% to $70.1 million in 2019, then slumped by 302.57% to -$142.0 million in 2020, then surged by 111.48% to $16.3 million in 2021, then jumped by 1677.91% to $289.8 million in 2022.
• Business Quant data shows ZBH's Asset Writedowns and Impairment at $289.8 million in Q4 2022, $3.0 million in Q2 2022, and $16.3 million in Q2 2021.